 The FDA has approved expanded labeling for Cumberland Pharmaceuticals Incs NASDAQ: CPIX Caldolor, an intravenously delivered formulation of ibuprofen, to now include use in pre-operative administration. The non-narcotic pain reliever can now be administered just before surgery to enable patients to wake up from their procedure in significantly less pain. 